Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

[video]Cubist CEO: We are not Pfizer
TheStreet.com
Tuesday, October 25, 2011 - 12:34pm
tags:
Pfizer, Adolor, Cubist, Pharma CEOs, M&A, Michael Bonney
Merck & Co. Inc. Third Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Tuesday, October 25, 2011 - 12:31pm
tags:
Merck, earnings
10 largest upcoming pharma patent losses in the US
Fierce Pharma
Tuesday, October 25, 2011 - 11:54am
tags:
Takeda, Actos, Forest Labs, Lexapro, Bristol-Myers Squibb, Plavix, AstraZeneca, Seroquel, Eli Lilly, Zyprexa, Pfizer, Lipitor, Merck, Singulair, Novartis, Diovan, Provigil, Teva Pharmaceuticals, Abbott Laboratories, TriCor
How Rick Perry's Flat-Tax Plan Would Accelerate Health Reform
Forbes
Tuesday, October 25, 2011 - 11:50am
tags:
taxes, healthcare reform, Rick Perry
Cell Therapeutics Inc. Earnings Cheat Sheet: Loss Widens, Falls Below Estimates
Yahoo/Wall St. Cheat Sheet
Tuesday, October 25, 2011 - 11:49am
tags:
earnings, Cell Therapeutics
Abbott Execs Predict Big Growth for Pharma Spinoff
Motley Fool
Tuesday, October 25, 2011 - 11:47am
tags:
Abbott Laboratories, spinoff
Biogen Idec Inc. Third Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Tuesday, October 25, 2011 - 11:47am
tags:
Biogen Idec, earnings
U.S. advisers recommend Gardasil HPV shots for boys
Yahoo/Reuters
Tuesday, October 25, 2011 - 11:46am
tags:
Gardasil, Merck, HPV, CDC
Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer
Seeking Alpha
Tuesday, October 25, 2011 - 10:49am
tags:
pancreatic cancer, Amgen, Celgene, Infinity, Oncolytics, Pharmacyclics, Immunomedics, Threshold Pharmaceuticals, Clovis Oncology, Novartis, Aduro BioTech, NewLink Genetics, Seattle Genetics, Bayer Schering, Astellas
Biotech Blunder Turned 20% Overnight Gain
Motley Fool
Tuesday, October 25, 2011 - 9:25am
tags:
Exelixis, medullary thyroid cancer, cabozantinib
GlobeImmune, Gilead team up on hepatitis B treatment
Bizjournals.com
Tuesday, October 25, 2011 - 9:21am
tags:
Gilead, GlobeImmune, hepatitis B, Tarmogens
2 Biotechs With Strong Pipelines
Seeking Alpha
Tuesday, October 25, 2011 - 9:20am
tags:
GTx, NPS Pharmaceuticals
Lilly Pulls Xigris From Markets After Sepsis Drug Fails Study
Bloomberg
Tuesday, October 25, 2011 - 9:14am
tags:
Eli Lilly, Xigris, sepsis
Novartis plans 2,000 jobs cuts despite profit rise
Yahoo/AP
Tuesday, October 25, 2011 - 9:13am
tags:
earnings, Novartis, layoffs
Amgen Third-Quarter Profit Beats Estimates on Higher Sales of Cancer Drugs
Bloomberg
Monday, October 24, 2011 - 10:38pm
tags:
earnings, Amgen
Momenta and Sandoz revise Lovenox deal; Sandoz will start selling generic in 4th quarter
Yahoo/AP
Monday, October 24, 2011 - 10:37pm
tags:
Sandoz, generics, Novartis, Momenta, Lovenox, Sanofi
Forbes Earnings Preview: Bristol-Myers Squibb
Forbes
Monday, October 24, 2011 - 10:35pm
tags:
earnings, Bristol-Myers Squibb
Sanofi names Meeker CEO of Genzyme
Bizjournals.com
Monday, October 24, 2011 - 4:14pm
tags:
Sanofi, Pharma CEOs, Genzyme, David Meeker
FDA approves first generic versions of Zyprexa
Yahoo/AP
Monday, October 24, 2011 - 4:09pm
tags:
FDA, Eli Lilly, Zyprexa, generics, bipolar disorder, schizophrenia, Teva Pharmaceuticals, Dr Reddy's, antipsychotics
Celgene Corp Third Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Monday, October 24, 2011 - 4:07pm
tags:
Celgene, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.